Table 2.
CLUSTER 2 (DIABETES) N = 163 90.6% on target | CLUSTER 5 (COPD) N = 180 85.3% on target | CLUSTER 7 (CHF) N = 140 73.7% on target | CLUSTER 8 (PM/ICD) N = 1635, 87,4% on target | |||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Subscale | Intervention after 3 months | Intervention after 12 months | P value (< 0.05) | Intervention after 3 months | Intervention after 12 months | P value (< 0.05) | Intervention after 3 months | Intervention after 12 months | P value (< 0.05) | Intervention after 12 months |
Median (interquartile range) | Median (interquartile range) | Median (interquartile range) | Median (interquartile range) | Median (interquartile range) | Median (interquartile range) | Median (interquartile range) | ||||
| ||||||||||
Enhanced care | 5.4 (5.2–5.8) | 5,8 (5,2–6) | <0.001 | 5.4 (4.8–5.8) | 5.6 (5–6) | 0.02 | 5.6 (5–5.85) | 5.8 (5.2–6) | 0.05 | 5.8 (5.4–6) |
Increased accessibility | 5 (4.5–5.25) | 5 (4,75–5,5) | <0.001 | 5 (4–5.5) | 4.75 (4.25–5.25) | 0.26 | 5 (4.5–5.25) | 5 (4.45–5.5) | 0.37 | 5.5 (5–5.75) |
Privacy and discomfort | 1 (1–1.25) | 1 (1–1,25) | 0.79 | 1 (1–1.25) | 1 (1–1.75) | 0.14 | 1.25 (1–2) | 1 (1–1.25) | <0.001 | 1 (1–1) |
Care personnel concerns | 1 (1–1.66) | 1,66 (1–2,33) | <0.001 | 2 (1.33–2.66) | 2.33 (1.33–2.3) | 0.39 | 2 (1–2.66) | 1.66 (1–2.33) | 0.34 | 1 (1–1.33) |
Kit as substitution | 3 (2.66–3.33) | 2,66 (2–3) | <0.001 | 2.66 (2–3.33) | 2.33 (2–3) | 0.20 | 2.66 (2.33–3) | 2.66 (2–3) | 0.50 | 2.33 (2–2.66) |
Satisfaction | 6 (5.66–6) | 6 (5,66–6) | 0.91 | 5.66 (5.66–6) | 6 (5.66–6) | 0.01 | 6 (5.33–6) | 6 (5.66–6) | 0.05 | 6 (5.66–6) |